Augmedix Inc expected to post a loss of 10 cents a share - Earnings Preview

Augmedix

15/03/2024 20:44

* Augmedix Inc  AUGX.OQ   AUGX.O  is expected to show a rise
in
quarterly revenue when it reports  results on March 18 for the
period ending December 31 2023
    * The San Francisco California-based  company is expected to
report a 42.5% increase in revenue to $12.466 million from $8.75
million a year ago, according to the mean estimate from 5
analysts, based on LSEG data.
    * ​LSEG's mean analyst estimate for Augmedix Inc is for a
loss
of 10 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Augmedix
Inc is
$6.50​, above​ its last closing price of $3.29. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Sep. 30 2023  -0.11       -0.12      -0.10     Beat    14.9
 Jun. 30 2023  -0.13       -0.13      -0.12     Beat    7.7
 Mar. 31 2023  -0.15       -0.15      -0.14     Beat    8.2​
 Dec. 31 2022  -0.15       -0.15      -0.15     Met     2.2
 ​​Sep.                    -0.17                        
 30 2022                                                
 Jun. 30 2022  -0.16       -0.15      -0.20     Missed  -29​
 Mar. 31 2022  -0.15       -0.15      -0.16     Missed  -4.9
 Dec. 31 2021  -0.15       -0.15      -0.15     Met     3.1
 This summary was machine generated March 15 at 20:44 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)